Copenhagen, Denmark; November 30, 2004 – Genmab A/S (CSE: GEN) announced today that the company’s Chief Executive Officer, Lisa N. Drakeman, Ph.D., will present at the ING 4th Annual European Healthcare Conference in London on December 7, 2004.

The conference takes place at ING’s offices at 60 London Wall on December 7 and 8, 2004 and presentations will be given by companies from sectors including biotech, medtech, specialty pharmaceuticals and pharmaceuticals.

“We are pleased to have the opportunity to communicate Genmab’s recent achievements and the progress made in our programs such as HuMax™-CD20 to the investment community in London,” said Dr. Drakeman.